CervoMed Inc. (CRVO): Total Assets
$22.88M
As of 2025-12-31
$25.99M
As of 2026-06-30
+76.5%
3-year compound annual growth
-3.8%
5-year compound annual growth
+26.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.88M | -46.9% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $43.08M | +332.0% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $9.97M | +139.9% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $4.16M | -89.0% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $37.84M | +36.5% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $27.73M | +15.0% | 2022-03-18, Balance as of period end |
| 2019-12-31 | $24.11M | +32.5% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $18.20M | -30.4% | 2020-03-17, Balance as of period end |
| 2017-12-31 | $26.15M | +49.5% | 2019-03-19, Balance as of period end |
| 2016-12-31 | $17.48M | +668.0% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $2.28M | -94.7% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $42.78M | +133.2% | 2016-03-25, Balance as of period end |
| 2013-12-31 | $18.34M | +649.9% | 2015-04-03, Balance as of period end |
| 2012-12-31 | $2.45M | -33.4% | 2014-04-23, Balance as of period end |
| 2011-12-31 | $3.67M | -34.1% | 2013-04-24, Balance as of period end |
| 2010-12-31 | $5.58M | n/a | 2012-05-21, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $31.00M | +108.2% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $59.87M | -5.3% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $19.07M | -13.4% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $7.45M | +33.1% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $37.66M | -3.0% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $353.77M | -26.6% |
Compare CRVO, CPHI, PRPH, MRKR side by side · Screen every company in Pharmaceutical Preparations ↗